Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: APVMA (Australian Pesticides and Veterinary Medicines Authority)
FUCIDIC ACID DIETHANOLAMINE; FRAMYCETIN SULFATE; NYSTATIN; PREDNISOLONE
DECHRA REGULATORY B.V.
diethanolamine fusidate(5mg/mL)+framycetin sulfate(5mg/mL) + others
MISC. AURAL, OPHTHALMIC, ORO/NASO PHARYNGEAL
FUCIDIC ACID DIETHANOLAMINE ANTIBIOTIC Active 5.0 mg/g; FRAMYCETIN SULFATE ANTIBIOTIC Active 5.0 mg/g; NYSTATIN ANTIBIOTIC Active 100000.0 IU/g; PREDNISOLONE STEROID-GLUCOCORTICOID Active 2.5 mg/g
15mL; 25mL
VM - Veterinary Medicine
DERMCARE-VET
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
EAR,NOSE,THROAT PREPS.
BACTERIAL DERMATITIS | OTITIS EXTERNA | ACUTE CANINE OTITIS | ASSOCIATED WITH YEAST &/OR BAC | CHRONIC CANINE OTITIS | MALASSEZIA PACHYDERMATIS | OTITIS (CANINE)
Poison schedule: 4; Withholding period: WHP: n/a.; Host/pest details: CAT: [BACTERIAL DERMATITIS, OTITIS EXTERNA]; DOG: [BACTERIAL DERMATITIS, OTITIS EXTERNA]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [BACTERIAL DERMATITIS, OTITIS EXTERNA]; DOG: [BACTERIAL DERMATITIS, OTITIS EXTERNA]; For treatment of otitis externa and dermatosis of bacterial origin in dogs and cats.Do not use where there is perforation of the eardrum.
Registered
2023-07-01
CANAURAL COMPOSITUM SUSPENSION FOR TREATMENT OF OTITIS EXTERNA & DERMATOSIS 35926/137606 Product Name: APVMA Approval No: Label Name: CANAURAL COMPOSITUM SUSPENSION FOR TREATMENT OF OTITIS EXTERNA & DERMATOSIS Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 5 mg/g Diethanolamine Fusidate 5 mg/g Framycetin Sulfate 100,000 IU/g Nystatin 2.5 mg/g Prednisolone Claims: For the treatment of otitis externa and dermatosis in dogs and cats. Net Contents: 15 mL 25 mL Directions for Use: Restraints: Contraindications: Not to be used where there is perforation of the eardrum. Not to be used concomitantly with products known to be ototoxic. Not to be used in animals with known hypersensitivity to the active constituents. Not recommended in pregnant or lactating animals. Precautions: Side Effects: Allergy or hypersensitivity reactions may occur. On very rare occasions and primarily in geriatric animals, use of auricular preparations may be associated with hearing impairment which may be either transient or prolonged. If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. RLP APPROVED Dosage and Administration: Shake well before using. Use the contents within 3 months of first broaching the vial/ container. Discard the unused portion. 5-10 drops of Canaural should be instilled into the ear canal twice daily. The ear flap should then be held and the ear canal gently massaged to ensure maximum penetration of the preparation. In the case of dermatosis it should be applied to the affected area. The length of treatment will depend upon the individual case. Ensure all visible discharge from treated animals is hygienically removed. Wash hands thoroughly after use of this product or contact with any discharge from the ears of treated animals. General Directions: Canaural Compositum is specifically formulated for the treatment of otitis externa in the dog and cat. Diethanolamine Fusidate is an ant Διαβάστε το πλήρες έγγραφο
Product: ................................ CANAURAL - AUS - LEAFLET Dimensions:........................................................... 140mm x 300mm Primary brand name font size: .................................................... 27pt Primary brand description font size:......................................... 16.2pt Body text font size: ..................................................................... 12pt Item code: ............................................................................... F1119 Pharmacode: ............................................................................... 189 Regulatory .................................................. Marketing ................................................... Technical .................................................... Date ........................... Date ........................... Date ........................... Date: Proof: 1(NH) 2(NH) 3(CC) 4(NH) 03-12-2014 04-12-2014 28-01-2015 29-01-2015 Date: Proof: Pantone reference guide Colours to be printed: Do not print BLACK CUTTER GUIDE STYLE DEVIATIONS NH BLACK - 50% BLACK - 30% BLACK - 20% COMPOSITION: Canaural is an oily suspension. 1 g suspension contains: Diethanolamine Fusidate 5 mg Framycetin Sulphate 5 mg Nystatin 100,000 i.u. Prednisolone 2.5 mg PROPERTIES: Canaural Compositum is specifically formulated for the treatment of otitis externa in the dog and cat. Diethanolamine Fusidate is an antibiotic which is highly active against _Staphylococci_, the most commonly found bacterial pathogen in otitis externa in the dog and cat. Diethanolamine Fusidate has skin penetrating properties which enhances its antibacterial activity. Framycetin Sulphate is a broad-spectrum antibiotic which has been incorporated for its activity against gram negative organisms associated with otitis externa, in particular _Pseudomonas_ spp. and _Proteus_ spp. Nystatin is highly active against fungi such as _Malassezia _ _pachydermatis_. _Malassezia_ is the most common fungi associated with otitis externa in the do Διαβάστε το πλήρες έγγραφο